Related Experiment Video
Updated: May 19, 2026

08:50
A Nonsequencing Approach for the Rapid Detection of RNA Editing
Published on: April 21, 2022
Altered A-to-I RNA editing in human embryogenesis
Ronit Shtrichman1, Igal Germanguz, Rachel Mandel
1The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Plos One
|August 4, 2012
Summary
Adenosine to Inosine RNA editing activity is significantly lower in fetal tissues compared to adult tissues. ADAR1 enzyme regulation in human embryonic stem cells suggests its critical role in early human development.
Area of Science:
- Molecular Biology
- Developmental Biology
- Genetics
Background:
- Post-transcriptional RNA modifications are crucial for human development.
- Adenosine to Inosine (A-to-I) RNA editing, catalyzed by ADAR enzymes, is a key post-transcriptional event.
- Understanding A-to-I RNA editing differences between embryonic and adult stages is vital.
Purpose of the Study:
- To investigate variations in A-to-I RNA editing activity and ADAR1 enzyme levels between human fetal and adult tissues.
- To explore the regulation of ADAR1-p110 isoform in human embryonic stem cells (hESCs) as a model for early development.
Main Methods:
- Analysis of A-to-I RNA editing in coding and non-coding sequences across five fetal and adult human tissues (brain, heart, liver, kidney, spleen).
- Assessment of ADAR1 enzyme transcriptional levels in these tissues and in hESCs.
- Attempted overexpression of ADAR1-p110 isoform in hESCs and embryonal carcinoma cells to study its regulation.
Main Results:
- Most adult tissues exhibited substantially greater A-to-I RNA editing activity compared to fetal tissues for six of eight tested genes.
- Overexpression of ADAR1-p110 in hESCs and embryonal carcinoma cells was unsuccessful, with protein levels decreasing post-infection.
- ADAR1 protein appears to be significantly regulated in undifferentiated pluripotent hESCs.
Conclusions:
- A-to-I RNA editing plays a critical role during early human development.
- The regulation of ADAR1 in pluripotent stem cells highlights its importance in embryogenesis.
- Differences in RNA editing activity may contribute to developmental variations between fetal and adult stages.
Related Concept Videos
RNA Editing
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
pre-mRNA Processing
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
piRNA - Piwi-interacting RNAs
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...

